학술논문
A Novel Aryl-Guanidinium Based Compound Targets the STAT3 Signalling Pathway, Downregulates MCL-1 Expression and Induces Anti-Myeloma Activity
Document Type
Abstract
Author
Source
In Blood 5 November 2020 136 Supplement 1:35-36
Subject
Language
ISSN
0006-4971